6th Annual Gene Therapy for Rare Disorders Europe

Temi della conferenza
As more and more companies gear up for clinical activity and near approval decisions, the need to have an in-depth understanding of the regulatory frameworks and how these feed into clinical development and manufacturing processes is as vital as ever.

Scientific organizer
Hanson Wade

Annotazioni
Speakers: Eva Andres-Mateos, Senior Director of Translational Research, Atsena Therapeutics, Inês Alves, Patient Expert and Member of the Committee for Orphan Medicinal Products, EMA, Stuart Beattie, Gene Therapy Global Regulatory CMC, Biogen

https://go.evvnt.com/1234024-2?pid=4832

Ms. Emily Birt